See accompanying notes to consolidated financial statements. View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate ...

TUCSON, Ariz., March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to ...

Accelerate Diagnostics ( (AXDX)) has released its Q3 earnings. Here is a breakdown of the information Accelerate Diagnostics presented to its investors. Accelerate Diagnostics, Inc. is a company ...

Accelerate Diagnostics, Inc. AXDX has secured FDA 510(k) clearance for its Accelerate Arc system and BC kit, designed for use with Bruker's MALDI Biotyper CA system (MBT-CA System) and MBT-CA ...

Tucson-based Accelerate Diagnostics Inc. on Thursday posted a smaller first-quarter loss, but its revenue fell below Wall Street expectations. The company, which makes an automated system to rapidly ...

Preliminary data indicate the rate of sepsis mortality related to overall patient deaths is dropping at University Health Care System in Augusta, Ga. So what are they doing differently? Accelerate ...

Operator: Good day, and welcome to the Accelerate Diagnostics Inc. Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Today’s remarks ...

TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate" or the Company") today announced that it has voluntarily initiated a Chapter 11 restructuring ...

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics’ current ...